Clinical trial · Observational
Urinary miRNA in Endometrial Cancer Study
Urinary microRNA Expression in Endometrial Cancer Patients - a Feasibility Study
NCT03824613CI-TRIAL-00050385completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a prospective feasibility study with the addition of a retrospective cohort study on the the expression of microRNA in urine in endometrial cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Urinary miRNA | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Endometrial cancer patients
- interventionNames
- Diagnostic Test: Urinary miRNA
- label
- Control group
- description
- Patients without cancer
- interventionNames
- Diagnostic Test: Urinary miRNA
Primary outcomes (1)
- measure
- Accuracy of predictive value of miRNA test in detecting endometrial cancer
- timeFrame
- 6 months
- description
- To determine if miRNA can distinguish endometrial cancer patients from healthy patients
Secondary outcomes (1)
- measure
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Confirmed diagnosis of endometrial cancer * Age: 18 years or older Exclusion Criteria: * Prior or coexisting other malignancies * Autoimmune disorders (other than diabetes mellitus)
References
Publications (0)
Data not yet available
No reference posted for this study.